(Q41220227)

28 September 2017

1 reference

title

Cardiac involvement in scleroderma (English)

1 reference

28 September 2017

Deswal A

1

1 reference

PubMed ID

8923599

28 September 2017

Follansbee WP

series ordinal

2

1 reference

28 September 2017

1 November 1996

1 reference

Rheumatic Diseases Clinics of North America

28 September 2017

1 reference

28 September 2017

22

1 reference

28 September 2017

4

1 reference

28 September 2017

841-860

1 reference

Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: A clinicopathologic study of 9 patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

A Semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

International study of ketanserin in Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Frequency of mitral valve prolapse in systemic lupus erythematosus, progressive systemic sclerosis and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Plasmapheresis and immunosuppressive drug therapy in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Temporal evolution of changes in left ventricular function induced by cold pressor stimulation. An assessment with radionuclide angiography and gold 195m

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The cardiovascular manifestations of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Hypertrophic nonobstructive cardiomyopathy in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Cardiovascular function in patients with progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Cardiac involvement in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Echocardiographic identification of cardiac abnormality in scleroderma and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Cold-induced reversible myocardial ischaemia in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Decreased coronary reserve in primary scleroderma myocardial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Prognostic importance of cardiac arrhythmias in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Scleroderma; based on a study of over 150 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Reversible myocardial perfusion defects during cold challenge in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Pericardial disease in scleroderma (systemic sclerosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Skeletal muscle involvement in progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The heart in scleroderma: noninvasive assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Frequency of late potentials in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Treatment of scleroderma heart by D-penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The heart in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The heart in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

The toxicity of D-penicillamine in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

A Double-blind Study of Prazosin in the Treatment of Raynaud's Phenomenon in Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Skeletal muscle involvement in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Pericardial tamponade in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Association of myositis and myocarditis in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Cyclosporin A in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

Clinical course of patients with scleroderma renal crisis treated with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970304-5

7 January 2021

10.1016/S0889-857X(05)70304-5

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8923599